6. Research suggests that of distributed naloxone kits, approximately 80 – 90 percent of naloxone doses are
administered by individuals actively using substances. Furthermore, risk of overdose is highest among certain
populations, including:
• individuals who have reduced tolerance of opioids (e.g., after leaving incarceration or abstinence-
based treatment; post-partum women who have stopped using; people who have gone through
withdrawal);
• individuals using opioids intravenously;
• individuals who have previously experienced an opioid overdose; and
• individuals using opioids with certain other substances
• individuals with opioid use disorder and complex co-occurring medical conditions.
Please describe specifically how your organization will distribute these doses to individuals at highest risk of
overdose (100 words):
7. Please describe your organization’s past or current efforts to distribute naloxone to high-risk populations,
including any data collected around kits distributed and overdose reversals reported (100 words):
All requests are subject to approval by MDHHS. Completion of this
form does not guarantee that the product will be provided to the
organization or in the amounts requested.
Naloxone provided by MDHHS is done so under the Naloxone Standing Order. For
more information, please refer to
http://www.legislature.mi.gov/documents/2015-2016/publicact/pdf/2016-
PA-0383.pdf
Educational Resources can be viewed and downloaded at the following links:
https://www.narcan.com/patients/patient-resources
https://www.narcan.com/first-responders/law-enforcement-roll-call-video
https://beawarebeprepared.com/resources/
If your entity wishes to obtain printed copies of these educational resources and/
or demonstration/training devices, please submit a request via email to
8.
MDHHS is utilizing the smartphone app OpiRescue to connect naloxone recipients to harm reduction and
treatment resources and collect overdose reversal data. Please select the following from the dropdown menu: